Search results for "Drugs"

showing 10 items of 747 documents

Illicit drugs consumption evaluation by wastewater-based epidemiology in the urban area of Palermo city (Italy)

2017

Introduction. A wastewater-based epidemiology approach was performed to estimate the drug consumption in Palermo city, the fifth largest city of Italy with a population of 671 696 inhabitants, and to investigate the monthly variability of drug loads in wastewater from different areas of the city. A seven-months detection campaign was conducted at the two wastewater treatment plants of the city. Methods. Following a pre-treatment, 32 samples of wastewater were analyzed by liquid chromatography-tandem mass spectrometry. Results. We estimated a mean cocaine use in Palermo of 0.19 g/day/1000 people, corresponding to 1.90 doses/1000 people and cannabinoids use of 2.85 g/day/1000 people, correspo…

drugs consumptionSettore ICAR/03 - Ingegneria Sanitaria-AmbientaleIllicit DrugsSubstance-Related DisorderscocaineamphetaminescannabinoidWastewaterSettore MED/42 - Igiene Generale E Applicatawastewater-based epidemiologyItalyTandem Mass Spectrometrywastewater analysiPrevalenceHumansdrugs consumption; wastewater analysis; wastewater-based epidemiology; cannabinoids; cocaine; amphetaminesChromatography High Pressure Liquid
researchProduct

Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide.

1990

V79 cells, genetically engineered to express active cytochromes P450IIB1 and P450IA1, were used to study the cytotoxicity and mutagenicity of cyclophosphamide and ifosfamide. Cyclophosphamide, tested up to a concentration of 2 mM, was not cytotoxic in V79 nor in the P450IA1-expressing V79-derived cell line XEM2. Pronounced cytotoxicity was, however, observed in the P450IIB1-expressing V79-derived cell line SD1. Induction of gene mutations (acquisition of 6-thioguanine resistance) was observed in SD1 cells as well, but the effects were weak. Ifosfamide was inactive in V79 cells, but was cytotoxic in SD1 cells. Ifosfamide mustard, an active metabolite of ifosfamide, was equally cytotoxic and …

endocrine systemCyclophosphamideHealth Toxicology and MutagenesisAntineoplastic AgentsPharmacologyChinese hamsterCell LineBiotransformationCricetinaemedicineAnimalsIfosfamideCytotoxicityCyclophosphamideBiotransformationIfosfamidebiologyGenetically engineeredPublic Health Environmental and Occupational Healthfood and beveragesrespiratory systembiology.organism_classificationCell cultureCytostatic drugsGenetic EngineeringResearch Articlemedicine.drugEnvironmental Health Perspectives
researchProduct

Nueva era en el combate contra el cáncer: Evolución y cáncer: progreso y tratamiento de tumores

2013

L’oncohematologia ha assistit en les últimes dècades a importants avenços en el tractament i supervivència. La toxicitat derivada de la quimioteràpia clàssica i la necessitat de millorar l’eficàcia i tolerància als tractaments han fet que es desencadene un allau d’activitat investigadora que constantment proporciona fruits. Gran part d’aquest esforç s’ha enfocat al desenvolupament de «teràpies diana» dirigides contra determinades alteracions funcionals, clau per a la supervivència de la cèl·lula tumoral. Així es pretén aconseguir major eficàcia en el tractament i que el pacient pague un menor cost en toxicitat. Avenços en altres disciplines de l’oncologia com l’epidemiologia, la cirurgia i …

evolucióncribado poblacionalmecanismes de resistènciafàrmacs antidianaresistance mechanismsbiologia; evolució; genèticaterapias dirigidas; fármacos anti diana; inhibidores tirosin kinasa; mecanismos de resistencia; cribado poblacionalevolutiontyrosine kinase inhibitorsteràpies dirigides; fàrmacs antidiana; inhibidors tirosina-cinasa; mecanismes de resistència; cribatge poblacionalinhibidores tirosin kinasageneticsteràpies dirigidesanti-target drugsbiologygenèticascreeningtargeted therapies; anti-target drugs; tyrosine kinase inhibitors; resistance mechanisms; screeningcribatge poblacionalmecanismos de resistenciatargeted therapiesevolución; biología; medicinaterapias dirigidasevoluciófármacos anti dianabiologíabiology; evolution; geneticsmedicinabiologiainhibidors tirosina-cinasa
researchProduct

Diversity of Pharmacological Properties in Chinese and European Medicinal Plants: Cytotoxicity, Antiviral and Antitrypanosomal Screening of 82 Herbal…

2011

In an extensive screening, the antiviral, antitrypanosomal and anticancer properties of extracts from 82 plants used in traditional Chinese medicine and European phytomedicine were determined. Several promising plants that were highly effective against hepatitis B virus (HBV), bovine viral diarrhoea virus (BVDV)—a flavivirus used here as a surrogate in vitro model of hepatitis C virus, trypanosomes (Trypanosoma brucei brucei) and several cancer cell lines were identified. Six aqueous extracts from Celosia cristata, Ophioglossum vulgatum, Houttuynia cordata, Selaginella tamariscina, Alpinia galanga and Alpinia oxyphylla showed significant antiviral effects against BVDV without toxic effects …

food.ingredientAlpinia galangagastrointestinal tumorsTrypanosoma brucei bruceiSelaginella tamariscinaPharmacologyHedyotis diffusaPhytomedicinetraditional Chinese medicinefoodHepG2 2.2.15Panax notoginsenglcsh:QH301-705.5BVDVNature and Landscape ConservationKadsura longipedunculataEcologybiologyEcological ModelingCoptis chinensisbiology.organism_classificationAgricultural and Biological Sciences (miscellaneous)Houttuynia cordataanticancer drugs; gastrointestinal tumors; traditional Chinese medicine; cytotoxicity; hepatitis B; hepatitis C; HepG2 2.2.15; BVDV; <em>Trypanosoma brucei brucei</em>anticancer drugslcsh:Biology (General)cytotoxicityhepatitis Bhepatitis CDiversity
researchProduct

Visual Health Nanocomposites: Present and Future

2021

Background: In recent years, the therapeutics for eye diseases as retinopathy diabetic, dry eye, glaucoma and contact lenses fabrication are including nanocompounds as ocular drug delivery systems, biomarkers for detection of eye diseases, copper and silver ions that has been incorporated by means of the nanotechnology for the production of less toxic and more effective alternatives. Several compounds such as silver nanoparticles, turmeric-based nanocomposites, neovascularization blockers and nanoparticles extracted from the plant Costus pictus among others have been researched for this purpose. Those compounds are some of the promising research efforts that are studying and will contribute…

genetic structuresBlindnessbusiness.industryGlaucomamedicine.diseaseBioinformaticseye diseasesSilver nanoparticleOphthalmic drugsRetinal neovascularizationCostus pictusmedicinesense organsbusinessRetinopathy
researchProduct

Witkaco-Gombrowiczowskie tęsknoty i pragnienia, czyli od metafizyki do estetyki : interpretacje Jerzego Jarockiego

2016

Artykuł prezentuje sylwetki dwóch fascynujących twórców dwudziestowiecznego polskiego dramatu, opisanych na przykładzie Grzebania1 i Błądzenia2 - spektakli Jerzego Jarockiego. Opowiada o tęsknotach, pragnieniach, fobiach Stanisława Ignacego Witkiewicza i Witolda Gombrowicza, z których pierwszy uporczywie dążył do formy, a drugi - od formy pragnął się wyzwolić. „Palę, piję i nic mi to nie szkodzi” - pisał Witkacy w przedmowie do swoich Narkotyków. Z kolei Gombrowicz ustawicznie pisał o sobie, czyniąc z siebie samego bohatera własnych utworów. Jako punkt wyjścia dla moich rozważań wybrałam odmienne sposoby poszukiwania i zaspokajania pragnień duchowych oraz cielesnych.

immaturity/old ageculture/naturelongingpragnieniewanderingGombrowiczniedojrzałość/starośćużywkiciało/duchWitkiewiczdrugsmetaphysics/aestheticsbłądzenietęsknotadesirekultura/naturabody/spiritmetafizyka/estetyka
researchProduct

Occurrence and control of selected antibiotics and antiretroviral drugs in urban hydrological cycles

2018

kaupunkiseudutpohjavesiantiretroviraaliset lääkeaineetantibiootitSambiasurface waterjätevesilääkeaineetsource separated urineantibioticspost-treatmenthydrologinen kiertoAfrikkataajamahydrologiapintavesijätevesikuormituspitoisuusgroundwaterSuomivirtsaantiretroviral drugswastewaterKeniajäteveden käsittely
researchProduct

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diab…

2017

Aims These recommendations aim to improve care for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk in Central and Eastern Europe. Cardiovascular disease (CVD) and/or chronic kidney disease (CKD) are major interdependent comorbidities in patients with T2D, accounting for 50% of mortality. Following recent CV outcomes trial (CVOT) results, including those from EMPA-REG OUTCOME®, LEADER®, SUSTAIN™-6 and, most recently, the CANVAS study, it is essential to develop regional expert consensus recommendations to aid physicians in interpreting these newest data to clinical practice. Methods The Central and Eastern European Diabetes Expert Group (CEEDEG) followed a Delphi method …

lcsh:Diseases of the circulatory (Cardiovascular) systemKeywords: Anti-glycaemic drugs ; Cardiovascular disease ; Renal disease ; Type 2 diabetesmedicine.medical_specialtyEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDelphi method610 Medicine & health030209 endocrinology & metabolismReviewType 2 diabetesDisease030204 cardiovascular system & hematologyAnti-glycaemic drugs2705 Cardiology and Cardiovascular MedicineTranslational Research BiomedicalRenal disease03 medical and health sciences0302 clinical medicineMultidisciplinary approachDiabetes mellitusDiabetes MellitusmedicineHumansHypoglycemic AgentsEurope EasternIntensive care medicineExpert TestimonyClinical Trials as Topicbusiness.industryType 2 diabetesCardiovascular diseasemedicine.diseaseExpert groupEuropeEastern european2712 Endocrinology Diabetes and MetabolismTreatment Outcome2724 Internal MedicineCardiovascular Diseaseslcsh:RC666-701Practice Guidelines as TopicCardiology and Cardiovascular MedicinebusinessKidney diseaseCardiovascular Diabetology
researchProduct

Use of Antihypertensive Drugs During Preeclampsia

2018

Treatment of pregnancy-related hypertensive disorders, such as preeclampsia (PE), remain a challenging problem in obstetrics. Typically, aggressive antihypertensive drug treatment options are avoided to prevent pharmacological-induced hypotension. Another major concern of administering antihypertensive drugs during pregnancy is possible adverse fetal outcome. In addition, management of hypertension during pregnancy in chronic hypertensive patients or in patients with prior kidney problems are carefully considered. Recent studies suggest that PE patients are at increased cardiovascular risk postpartum. Therefore, these patients need to be monitored postpartum for the subsequent development o…

lcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyhypertensionmedicine.drug_classMini ReviewCardiovascular MedicinePreeclampsiapreeclampsia03 medical and health sciences0302 clinical medicineMedicineIn patient030212 general & internal medicineAntihypertensive drugIntensive care medicinePregnancy030219 obstetrics & reproductive medicinebusiness.industrycardiovascularTreatment optionsmedicine.diseaseReview articlelcsh:RC666-701antihypertensive drugsFetal outcomepregnancyCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct

The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma

2018

Purpose: While recent studies described the role of IKZF1/3 proteins in multiple myeloma (MM) cells, few have highlighted the significance of IKZF1/3 expression in T-cells. In this study we examine the prognostic and predictive value of IKZF1/3 expression in T-cells in patients with MM stage III. Experimental design: We analysed the IKZF1/3 expression levels in T-cells from 45 MM stage I (MMI) and 50 newly diagnosed MM stage III (MMIII) patients, according to Durie-Salmon staging system, by flow cytometry to examine their prognostic and predictive value. We also combined in vivo observations with in vitro assays to determine the effect of IKZF1/3 expression on the T-cell immunophenotype and…

lcsh:Immunologic diseases. Allergy0301 basic medicineOncologymedicine.medical_specialtyImmunologyMedizinlcsh:RC254-282Flow cytometry03 medical and health sciencesikzf10302 clinical medicineImmunophenotypingikzf3immunomodulatory drugsIn vivoInternal medicinemedicineImmunology and AllergyStage (cooking)t cellsMultiple myelomaOriginal ResearchLenalidomidemedicine.diagnostic_testbusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasePomalidomidemultiple myelomaThalidomide030104 developmental biologyOncologybiomarker trialsimmunelcsh:RC581-607business030215 immunologymedicine.drug
researchProduct